O26.32 Retained intrauterine contraceptive device in pregnancy, second trimester

Name of the Condition

• Retained intrauterine contraceptive device in pregnancy, second trimester
• ICD Code: O26.32

Summary

Retained intrauterine contraceptive device (IUCD) in pregnancy, second trimester, refers to the presence of an IUCD remaining in the uterine cavity during the second trimester of pregnancy. This condition requires evaluation to assess potential risks to the pregnancy and maternal health, as the device may interfere with fetal development or increase complications. Management focuses on balancing risks of removal versus leaving the device in place.

Causes

The primary cause is the failure to remove an IUCD prior to conception. This may occur due to unawareness of pregnancy, missed follow-up appointments, or delayed recognition of pregnancy after IUCD placement. In some cases, the device may be retained inadvertently if not detected during routine prenatal care.

Risk Factors

Risk factors include lack of prenatal care, delayed pregnancy recognition, or failure to remove the IUCD as recommended before conception. Women with a history of IUCD use who become pregnant without prior removal are at increased risk. The second trimester timing may reflect delayed detection or delayed decision-making regarding device removal.

Symptoms

Symptoms may include vaginal bleeding, pelvic pain, or signs of infection. However, many cases are asymptomatic and detected incidentally during routine prenatal imaging or physical examination. The second trimester may present with more noticeable symptoms due to uterine growth.

Diagnosis

Diagnosis is typically made through ultrasound imaging, which can visualize the IUCD within the uterine cavity. Clinical evaluation may include assessment of fetal position, placental location, and device placement relative to these structures. Additional imaging or monitoring may be used to evaluate potential complications.

Treatment Options

Treatment depends on individual circumstances and may involve monitoring, device removal, or leaving the device in place. Removal may be considered if the device is accessible and the risks of removal are deemed acceptable. If left in place, close monitoring for complications is essential.

Prognosis and Follow-Up

Prognosis varies based on factors such as device location, fetal development, and maternal health. Close follow-up with prenatal care is critical to monitor for complications like infection, preterm labor, or fetal anomalies. Outcomes are generally better with early detection and appropriate management.

Complications

Potential complications include infection, miscarriage, preterm birth, or fetal injury. The device may also interfere with placental implantation or cause uterine perforation. Maternal risks include pelvic inflammatory disease or uterine trauma during removal.

Lifestyle & Prevention

Prevention focuses on ensuring IUCD removal before attempting pregnancy and confirming device expulsion or removal through follow-up care. Women using IUCDs should be counseled on the importance of timely removal and early pregnancy testing if conception is possible.

When to Seek Professional Help

Seek medical attention for symptoms like vaginal bleeding, severe pelvic pain, fever, or signs of infection. Regular prenatal care is essential for early detection and management of this condition.

Tips for Medical Coders

Document the presence of the retained IUCD, its location, and any associated complications. Note the trimester (second trimester for O26.32) and any management decisions. Ensure documentation supports the need for monitoring or intervention related to the device during pregnancy.